"Solve the undissolvable" - Article in Platform Life Sciences

CSO Dr. Eva Prieschl-Grassauer is talking about the low solubility of hydrophobic active ingredients, the associated problems of bioavailability and efficacy, and new solutions for drug development. Read the full article here (p. 58):